The present invention relates to FGFR4 antibodies including fragments or derivatives thereof and the polynucleotides encoding the antibodies. Expression vectors and host cells comprising the polynucleotides are provided. Further, the invention refers to pharmaceutical compositions comprising the FGFR4 antibodies and methods for the treatment, prevention or diagnosis of disorders associated with FGFR4 expression.

 
Web www.patentalert.com

< Molecular characteristics of non-small cell lung cancer

< Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines

> Ligand-regulable transactivation systems, methods of use thereof, methods of detecting estrogen receptor ligands, and methods of differentiating estrogen receptor ligand agonists and antagonists

> ANIMAL MODEL
~ 00619